Pre-surgical high resolution ultrasound of facial basal cell carcinoma: correlation with histology

Francisco Bobadilla, Ximena Wortsman, Carla Muñoz, Laura Segovia, Miguel Espinoza, Gregor B E Jemec, Francisco Bobadilla, Ximena Wortsman, Carla Muñoz, Laura Segovia, Miguel Espinoza, Gregor B E Jemec

Abstract

The aim of this study was to analyze the scope of pre-surgical high resolution ultrasound in basal cell carcinoma (BCC). BCC is the most common human cancer. According to recent large prospective studies incomplete excision of BCC is higher than expected. Pre-operative imaging may aid surgical planning by identifying the extent and location of a neoplasm, which can be interesting at zones with higher risk of recurrences such as the face. These are slow growing tumors but there are some aggressive types described that can involve deeper structures. Twenty-five patients were studied (10 F/15 M, 48-91 years old; mean age 69.5+/-11.5 years) with suspicious facial lesions < or =1.5 cm. Pre-surgical ultrasound with compact linear 15-7 MHz probe was performed. Ultrasound reported the morphology and thickness of the tumors. The results were correlated with the histology. Ultrasound identified 29 suspicious facial lesions that were removed with tumor-free borders at the first surgery and confirmed by histology. The main location was the nose. Two subclinical satellite lesions at the nasal zone were detected under ultrasound which led to a change in the surgery plan. The intraclass correlation coefficient (ICC) value was used to compare tumor thickness measurements between ultrasound and histology. ICC was considered as very good (0.9). Therefore, ultrasound can be useful to plan BCC surgery, it can recognize lesions, layers of involvement and vascularity patterns in a non-invasive way. It can show subclinical satellite lesions, even though the number of subclinical cases is small and require further investigations. It has a good thickness correlation with histology and may be used as a technique to monitor disease changes following non-invasive medical treatments in the future.

Figures

Figure 1
Figure 1
Compact linear probe, 15–7 MHz (variable frequency) used for the study.
Figure 2
Figure 2
Thickness (mm) correlation distribution between ultrasound and histology. Inside the orange circles are the two pitfall cases of the study.
Figure 3
Figure 3
Distribution of the location of the BCC lesions (%).
Figure 4
Figure 4
Histological distribution of the BCC lesions.
Figure 5
Figure 5
BCC tumor ultrasound shows an oval and hypoechoic lesion. Three thickness measurements (between calipers) demonstrate the irregularities at the deep borders that generate different distances. For the purpose of this study the largest distance was considered.
Figure 6
Figure 6
Color Doppler ultrasound shows the distribution of vessels (in red and blue) inside and at the deep portion of the tumor.
Figure 7
Figure 7
Spectral curve analysis color Doppler ultrasound of the arterial flow inside the tumor demonstrates the peak systolic velocity (circle) and the resistance index (arrow).
Figure 8
Figure 8
Ultrasound (a) and histology (b) of the same case showing a thickness difference of less than 1 mm (0.7 mm) between the methods and corresponding to a patient with a tumor measuring 4.2 mm thick by ultrasound and 3.5 mm by histology. Calipers are marking the lateral extension of the lesion, not the depth. Note the similar shape of the tumor under ultrasound and under 2 × zoom hematoxylin/eosin stain in histology.
Figure 9
Figure 9
Ultrasound of a case later described by histology as surrounded with sebaceous hyperplasia that overestimated the size of the tumor. Calipers show the measurements that were included in the ultrasound report. The (C) mark corresponds to the cartilage at the nasal ala. Notice the coarse, fuzzy and heterogeneous echoic pattern of the tissue, which differs from the lesions previously seen. Tumor and sebaceous hyperplasia zones are marked.
Figure 10
Figure 10
Histology of the same tumor as the patient in Fig. 9. The tumor is located between arrows and the rest was reported as sebaceous hyperplasia.
Figure 11
Figure 11
Ultrasound of a case described in histology as thickness overestimation because of the presence of a giant cell inflammatory reaction at the deepest portion. (a) Calipers show the actual measurements done by the ultrasound operator. In (b) the red lines show the angles formed by the inflammatory reaction at the profound part of the lesion. The tumor (T) was only located at the superficial area before the angles are formed.
Figure 12
Figure 12
Cutaneous frontal outflap surgery in a case with three BCC focuses on the nose. Two of the three focuses were subclinical and detected only at the ultrasound examination.
Figure 13
Figure 13
Post op result of the same patient as Fig. 9 after removal of all three BCC focuses in one time surgery.

References

    1. Miller SJ. Biology of basal cell carcinoma (Part I) J Am Acad Dermatol. 1991;24:1–13.
    1. Chuang TY, Popescu A, Su WP, Chute CG. Basal cell carcinoma: a population-based incidence study in Rochester, Minnesota. J Am Acad Dermatol. 1990;22:413–17.
    1. Wong CS, Strange RC, Lear JT. Basal cell carcinoma. BMJ. 2003;327:794–8.
    1. Strasswimmer J, Pierce MC, Park BH, Neel V, de Boer JF. Polarization-sensitive optical coherence tomography of invasive basal cell carcinoma. J Biomed Opt. 2004;9:292–8.
    1. Preminger BA, Talmor M, Specht MC, Suzman M, Hoffman LA. The legacy of Icarus in the 21st century: report of a case of aggressive submental basal cell carcinoma resulting from frequent use of a metallic ultraviolet reflector. Ann Plast Surg. 2001;46:192–3.
    1. Cernea CR, Ferraz AR, de Castro IV, et al. p53 and skin carcinomas with skull base invasion: a case-control study. Otolaryngol Head Neck Surg. 2006;134:471–5.
    1. Villalon-Lopez JS, Valle-Mejia CA, Patino-Lara A, Moreno-Perez BA, Munoz-Lopez JA, Alcantar-Andrade A. Supraestructure maxillectomy and orbital exenteration for treatment of basal cell carcinoma of inferior eyelid: case report and review. J Cancer Res Ther. 2006;2:140–3.
    1. Ansarin H, Daliri M, Soltani-Arabshahi R. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma. Eur J Dermatol. 2006;16:543–7.
    1. Essers BA, Dirksen CD, Nieman FH, et al. Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face. Arch Dermatol. 2006;142:187–94.
    1. Su SY, Giorlando F, Ek EW, Dieu T. Incomplete excision of basal cell carcinoma: a prospective trial. Plast Reconstr Surg. 2007;120:1240–8.
    1. Bogelund FS, Philipsen PA, Gniadecki R. Factors affecting the recurrence rate of basal cell carcinoma. Acta Dermatol Venereol. 2007;87:330–4.
    1. Farhi D, Dupin N, Palangie A, Carlotti A, Avril MF. Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases. Dermatol Surg. 2007;33:1207–14.
    1. Kumar P, Orton CI, McWilliam LJ, Watson S. Incidence of incomplete excision in surgically treated basal cell carcinoma: a retrospective clinical audit. Br J Plast Surg. 2000;53:563–6.
    1. Bogdanov-Berezovsky A, Cohen AD, Glesinger R, Cagnano E, Krieger Y, Rosenberg L. Risk factors for incomplete excision of basal carcinomas. Acta Derm Venereol. 2004;84:44–7.
    1. Griffiths RW. Audit of histologically incompletely excised basal cell carcinomas: recommendations for management by re-excision. Br J Plast Surg. 1999;52:24–8.
    1. Nagore E, Grau C, Molinero J, Fortea JM. Positive margins in basal cell carcinoma: relationship to clinical features and recurrence risk. A retrospective study of 248 patients. J Eur Acad Dermatol Venereol. 2003;17:167–70.
    1. Thissen MR, Neumann MH, Schouten LJ. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol. 1999;135:1177–83.
    1. Mogensen M, Jemec GB. Diagnosis of nonmelanoma skin cancer/keratinocyte carcinoma: a review of diagnostic accuracy of nonmelanoma skin cancer diagnostic tests and technologies. Dermatol Surg. 2007;33:1158–74.
    1. Wortsman XC, Holm EA, Wulf HC, Jemec GB. Real-time spatial compound ultrasound imaging of skin. Skin Res Technol. 2004;10:23–31.
    1. Wortsman X, Jemec GBE. [High resolution ultrasound applications in dermatology] Rev Chilena Dermatol. 2006;22:37–45 (in Spanish).
    1. Schmid-Wendtner MH, Burgdorf W. Ultrasound scanning in dermatology. Arch Dermatol. 2005;141:217–24.
    1. Lassau N, Spatz A, Avril MF, et al. Value of high-frequency US for preoperative assessment of skin tumors. Radiographics. 1997;17:1559–65.
    1. Ruocco E, Argenziano G, Pellacani G, Seidenari S. Noninvasive imaging of skin tumors. Dermatol Surg. 2004;30((2 Pt 2):):301–10.
    1. Gupta AK, Turnbull DH, Foster FS, et al. High frequency 40-MHz ultrasound. A possible noninvasive method for the assessment of the boundary of basal cell carcinomas. Dermatol Surg. 1996;22:131–6.
    1. Cammarota T, Pinto F, Magliaro A, Sarno A. Current uses of diagnostic high-frequency US in dermatology. Eur J Radiol. 1998;27(suppl 2):S215–23.
    1. Rallan D, Harland CC. Ultrasound in dermatology—basic principles and applications. Clin Exp Dermatol. 2003;28:632–8.
    1. Stiller MJ, Gropper CA, Shupack JL, Lizzi F, Driller J, Rorke M. Diagnostic ultrasound in dermatology: current uses and future potential. Cutis. 1994;53:44–8.
    1. Fornage BD, McGavran MH, Duvic M, Waldron CA. Imaging of the skin with 20 MHz US. Radiology. 1993;189:69–76.
    1. Clement A, Hoeffel C, Fayet P, et al. Value of high frequency (20 mHz) and Doppler ultrasound in the diagnosis of pigmented cutaneous tumors. J Radiol. 2001;82:563–71.
    1. Jemec GB, Gniadecka M, Ulrich J. Ultrasound in dermatology. Part I. High frequency ultrasound. Eur J Dermatol. 2000;10:492–7.
    1. Desai T, Desai A, Horowitz D, Kartono F, Wahl T. The use of high frequency ultrasound in the evaluation of superficial and nodular basal cell carcinomas. Dermatol Surg. 2007;33:1220–7.
    1. Vaillant L, Grognard C, Machet L, et al. [High resolution ultrasound imaging: value in treatment of basocellular carcinoma by cryosurgery] Ann Dermatol Venereol. 1998;125:500–4. in French.
    1. Humphrey S, Walsh NM, Delaney L, Propperova I, Langley RG. Prognostic significance of vascularity in cutaneous melanoma: pilot study using in vivo confocal scanning laser microscopy. J Cutan Med Surg. 2006;10:122–7.
    1. Wortsman X, Jemec GB. Real-time compound imaging ultrasound of hidradenitis suppurativa. Dermatol Surg. 2007;33:1340–2.
    1. Machet L, Ossant F, Bleuzen A, Grégoire JM, Machet MC, Vaillant L. [High-resolution ultrasonography: utility in diagnosis, treatment, and monitoring dermatologic diseases] J Radiol. 2006;87((12 Pt 2):):1946–61. in French.
    1. Solivetti FM, Di Luca Sidozzi A, Pirozzi G, Coscarella G, Brigida R, Eibenshutz L. Sonographic evaluation of clinically occult in-transit and satellite metastases from cutaneous malignant melanoma. Radiol Med (Torino) 2006;111:702–8. in English, Italian.
    1. Lassau N, Chami L, Peronneau P. [Imaging of melanoma: accuracy of ultrasonography before and after contrast injection for diagnostic and early evaluation of treatments] Bull Cancer. 2007;94:93–8. in French.
    1. Essers BA, Dirksen CD, Nieman FH, et al. Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face. Arch Dermatol. 2006;142:187–94.
    1. Uhara H, Hayashi K, Koga H, Saida T. Multiple hypersonographic spots in basal cell carcinoma. Dermatol Surg. 2007;30:1215–19.
    1. Mantovani E, Doro D, Milizia E, Steindler P. Recurrent eyelid basal cell carcinoma with sclerochoroidal infiltration: echographic findings. Ophthalmologica. 1998;212(Suppl 1):40–1.

Source: PubMed

3
Subskrybuj